Category: Disclosures

[Disclosure] HPSP (403870) – Change of CEO / 2025-11-07

November 7, 2025August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary HPSP has appointed Choon-heung Lee as its new CEO, replacing former CEO Geun-young Kim. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Changes in Executive Officers and Governance Structure This filing is a routine notification of a change…

Semiconductors, Disclosures

[Disclosure] HPSP (403870) – Decision on Closure of Shareholders Record for Cash/In-Kind Dividend (Record Date) / 2025-11-07

November 7, 2025August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary HPSP set December 31, 2025, as the record date to determine eligible shareholders entitled to receive potential cash dividends for the 9th fiscal year. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Subsequent Regulatory Filings Regarding Dividend Approval…

Semiconductors, Disclosures

[Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-11-06

November 6, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued a correction disclosure increasing the contract amount from approx. KRW 198.5B to approx. KRW 275.1B and extending the contract period and disclosure postponement period to December 31, 2034, at the customer’s request regarding the contract manufacturing agreement originally disclosed on May 26,…

Disclosures, Bio & Healthcare

[Disclosure] ALTEOGEN (196170) – Resolution on Submission of Agenda for Approval of Delisting / 2025-11-06

November 6, 2025August 5, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ALTEOGEN resolved to submit an agenda for conditional delisting from the KOSDAQ market to the Extraordinary General Meeting of Shareholders (EGM) on December 8, 2025, for the purpose of transferring its listing to the KOSPI market. 📊 [Key Disclosure Details & Major Figures Summary] 📝 Editor’s…

Disclosures, Bio & Healthcare

[Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2025-11-06

November 6, 2025August 2, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Following the exercise of stock options, 6,700 new common shares of Hana Micron will be issued and newly listed on the market on November 11, 2025. 📊 Key Disclosure Content & Financial Figures Summary 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Total Outstanding Shares…

Semiconductors, Disclosures

[Disclosure] ALTEOGEN (196170) – Resolution on Convocation of Extraordinary General Meeting of Shareholders / 2025-11-06

November 6, 2025August 5, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ALTEOGEN will hold an Extraordinary General Meeting of Shareholders (EGM) on December 8, 2025, at the Daejeon Convention Center to vote on the approval of conditional delisting from KOSDAQ and transfer listing to KOSPI. Electronic voting will also be conducted. 📊 [Key Disclosure Details & Major…

Disclosures, Bio & Healthcare

[Disclosure] ALTEOGEN (196170) – Closure of Register of Shareholders or Setting of Record Date / 2025-11-06

November 6, 2025August 5, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ALTEOGEN set November 21, 2025, as the record date to determine eligible shareholders for its upcoming Extraordinary General Meeting of Shareholders (EGM). 📊 [Key Disclosure Details & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Shareholder Determination and EGM Convocation Notice This…

Disclosures, Bio & Healthcare

[Disclosure] Wonik IPS (240810) – Matters Related to Obligation of Disclosure on Major Issues (Fair Disclosure) / 2025-11-05

November 5, 2025August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Wonik IPS has announced its 3-year dividend policy for 2025–2027, planning to gradually increase its payout ratio from approximately 12% to 14% based on separate net income to enhance dividend predictability. 📊 [Key Disclosure Contents & Summary Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification…

Semiconductors, Disclosures

[Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-11-04

November 4, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued a correction disclosure substantially increasing the contract amount from approx. KRW 242.0B to approx. KRW 517.9B and extending the contract period and disclosure postponement period to December 31, 2033, at the customer’s request regarding the contract manufacturing agreement originally disclosed on May…

Disclosures, Bio & Healthcare

[Disclosure] Daeduck Electronics (353200) – Provisional Operating Results (Consolidated Financial Basis) / 2025-11-04

November 4, 2025August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Daeduck Electronics disclosed that its Q3 2025 consolidated operating profit reached KRW 24.45B, up 165.2% year-on-year and up 1,210.1% quarter-on-quarter. 📊 Key Disclosure Contents & Major Figures 1. Q3 2025 Consolidated Provisional Financial Results 2. Q3 2025 Cumulative Consolidated Provisional Financial Results 3. Information Provision and…

Semiconductors, Disclosures